In this study, through transcriptome analysis of hepatic gene expression from three mouse models of liver inflammation and injury, we identified IGF2BP2, an m6A reader, as a key factor that drives NASH progression. The gene discussed is IGF2BP2; the disease is metabolic dysfunction-associated steatohepatitis.